Protocol

A targeted safety study, EPI-ZOSTER-030 VS US DB, to evaluate the safety of Shingrix in adults ≥ 50 years of age in the United States

September 11, 2020

Authors:

Harvard Pilgrim Health Care Institute, CVS Health, Carelon Research, Humana HealthCare, Optum Epidemiology, GlaxoSmithKline

Capability:

Validation Studies & Algorithm Development

Multi-Site Methods & Coordination

Expertise:

Regulatory Research & Support

RWE Research & Consulting